151 related articles for article (PubMed ID: 28903362)
1. Cell-free circulating DNA integrity is an independent predictor of impending breast cancer recurrence.
Cheng J; Cuk K; Heil J; Golatta M; Schott S; Sohn C; Schneeweiss A; Burwinkel B; Surowy H
Oncotarget; 2017 Aug; 8(33):54537-54547. PubMed ID: 28903362
[TBL] [Abstract][Full Text] [Related]
2. Circulating free DNA integrity and concentration as independent prognostic markers in metastatic breast cancer.
Cheng J; Holland-Letz T; Wallwiener M; Surowy H; Cuk K; Schott S; Trumpp A; Pantel K; Sohn C; Schneeweiss A; Burwinkel B
Breast Cancer Res Treat; 2018 May; 169(1):69-82. PubMed ID: 29340881
[TBL] [Abstract][Full Text] [Related]
3. Plasma DNA integrity as a biomarker for primary and metastatic breast cancer and potential marker for early diagnosis.
Madhavan D; Wallwiener M; Bents K; Zucknick M; Nees J; Schott S; Cuk K; Riethdorf S; Trumpp A; Pantel K; Sohn C; Schneeweiss A; Surowy H; Burwinkel B
Breast Cancer Res Treat; 2014 Jul; 146(1):163-74. PubMed ID: 24838941
[TBL] [Abstract][Full Text] [Related]
4. Circulating cell-free DNA variables as marker of ovarian cancer patients: A pilot study.
Stamenkovic S; Cheng J; Surowy H; Burwinkel B; Gündert M
Cancer Biomark; 2020; 28(2):159-167. PubMed ID: 32176629
[TBL] [Abstract][Full Text] [Related]
5. Plasma cell-free DNA integrity plus circulating tumor cells: a potential biomarker of no distant metastasis breast cancer.
Wang W; Liang M; Ma G; Li L; Zhou W; Xia T; Xie H; Wang S
Neoplasma; 2017; 64(4):611-618. PubMed ID: 28485169
[TBL] [Abstract][Full Text] [Related]
6. A Case-Control Study by ddPCR of ALU 260/111 and LINE-1 266/97 Copy Number Ratio in Circulating Cell-Free DNA in Plasma Revealed LINE-1 266/97 as a Potential Biomarker for Early Breast Cancer Detection.
Bortul M; Giudici F; Tierno D; Generali D; Scomersi S; Grassi G; Bottin C; Cappelletti MR; Zanconati F; Scaggiante B
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239866
[TBL] [Abstract][Full Text] [Related]
7. Cell-Free Circulating DNA Integrity Based on Peripheral Blood as a Biomarker for Diagnosis of Cancer: A Systematic Review.
Cheng J; Tang Q; Cao X; Burwinkel B
Cancer Epidemiol Biomarkers Prev; 2017 Nov; 26(11):1595-1602. PubMed ID: 28830871
[No Abstract] [Full Text] [Related]
8. Limited Utility of Circulating Cell-Free DNA Integrity as a Diagnostic Tool for Differentiating Between Malignant and Benign Thyroid Nodules With Indeterminate Cytology (Bethesda Category III).
Thakur S; Tobey A; Daley B; Auh S; Walter M; Patel D; Nilubol N; Kebebew E; Patel A; Jensen K; Vasko V; Klubo-Gwiezdzinska J
Front Oncol; 2019; 9():905. PubMed ID: 31620364
[No Abstract] [Full Text] [Related]
9. Alter circulating cell-free DNA variables in plasma of ovarian cancer patients.
Yu Z; Qin S; Wang H
J Obstet Gynaecol Res; 2019 Nov; 45(11):2237-2242. PubMed ID: 31502389
[TBL] [Abstract][Full Text] [Related]
10. Plasma ALU-247, ALU-115, and cfDNA Integrity as Diagnostic and Prognostic Biomarkers for Breast Cancer.
Hussein NA; Mohamed SN; Ahmed MA
Appl Biochem Biotechnol; 2019 Mar; 187(3):1028-1045. PubMed ID: 30151636
[TBL] [Abstract][Full Text] [Related]
11. Plasma Cell-Free DNA Integrity Assessed by Automated Electrophoresis Predicts the Achievement of Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer.
Cirmena G; Ferrando L; Ravera F; Garuti A; Dameri M; Gallo M; Barbero V; Ferrando F; Del Mastro L; Garlaschi A; Friedman D; Fregatti P; Ballestrero A; Zoppoli G
JCO Precis Oncol; 2022 Feb; 6():e2100198. PubMed ID: 35201850
[TBL] [Abstract][Full Text] [Related]
12. Plasma cell-free DNA integrity: a potential biomarker to monitor the response of breast cancer to neoadjuvant chemotherapy.
Wang W; Zhang W; Su L; Sang J; Wang S; Yao Y
Transl Cancer Res; 2019 Aug; 8(4):1531-1539. PubMed ID: 35116896
[TBL] [Abstract][Full Text] [Related]
13. The integrity of cfDNA in follicular fluid and spent medium from embryo culture is associated with embryo grade in patients undergoing in vitro fertilization.
Pan M; Shi H; Liu Z; Dong J; Cai L; Ge Q
J Assist Reprod Genet; 2021 Dec; 38(12):3113-3124. PubMed ID: 34820723
[TBL] [Abstract][Full Text] [Related]
14. High Cell-Free DNA Integrity Is Associated with Poor Breast Cancer Survival.
Lamminaho M; Kujala J; Peltonen H; Tengström M; Kosma VM; Mannermaa A
Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572906
[TBL] [Abstract][Full Text] [Related]
15. Prediction of breast tumor progression by integrity of free circulating DNA in serum.
Umetani N; Giuliano AE; Hiramatsu SH; Amersi F; Nakagawa T; Martino S; Hoon DS
J Clin Oncol; 2006 Sep; 24(26):4270-6. PubMed ID: 16963729
[TBL] [Abstract][Full Text] [Related]
16. Quantification of LINE1 in circulating DNA as a molecular biomarker of breast cancer.
Sunami E; Vu AT; Nguyen SL; Giuliano AE; Hoon DS
Ann N Y Acad Sci; 2008 Aug; 1137():171-4. PubMed ID: 18837943
[TBL] [Abstract][Full Text] [Related]
17. Circulating cell-free DNA and its integrity as a prognostic marker for breast cancer.
Iqbal S; Vishnubhatla S; Raina V; Sharma S; Gogia A; Deo SS; Mathur S; Shukla NK
Springerplus; 2015; 4():265. PubMed ID: 26090312
[TBL] [Abstract][Full Text] [Related]
18. The role of circulating cell-free DNA and its integrity as a biomarker for diagnosis of breast cancer using ALU (247/115) bP sequences.
Abd El Hafeez HA; Abd El Rahman MZ; Kamel TM; Rezk KM; Mohamed FM; Abdel-Hameed ZA
Egypt J Immunol; 2023 Jul; 30(3):44-55. PubMed ID: 37439529
[TBL] [Abstract][Full Text] [Related]
19. Estimation of ALU Repetitive Elements in Plasma as a Cost-Effective Liquid Biopsy Tool for Disease Prognosis in Breast Cancer.
Nair MG; Ramesh RS; Naidu CM; Mavatkar AD; V P S; Ramamurthy V; Somashekaraiah VM; C E A; Raghunathan K; Panigrahi A; Das M; Dhar SK; Prabhu JS
Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831397
[TBL] [Abstract][Full Text] [Related]
20. Circulating plasma DNA and DNA integrity in breast cancer patients undergoing neoadjuvant chemotherapy.
Lehner J; Stötzer OJ; Fersching D; Nagel D; Holdenrieder S
Clin Chim Acta; 2013 Oct; 425():206-11. PubMed ID: 23916787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]